Skip to content
Finance Investment, Oil Mining Resources

Northern Minerals (ASX: NTU) – Exceptionally high-grade Rare-Earth assays returned over wide mineralised intervals at Wolverine.

Northern Minerals Limited (ASX: NTU) 2 mins read

Perth, Western Australia – April 22, 2024 – Northern Minerals Limited (ASX: NTU), a leader in heavy rare earth (HRE) exploration and development, is thrilled to announce the receipt of high-grade assay results from its ongoing mineral resource definition drilling program at the Wolverine deposit, part of the Browns Range Project in Western Australia.

The latest assays confirm the presence of wide and high-grade mineralized intervals across the Wolverine deposit, which remains open at depth. Significant new intercept results include 15.6m at 9.99% Total Rare Earth Oxides (TREO) from a depth of 428.20m and other substantial intercepts demonstrating consistent mineralization across the targeted areas.

The drilling program at Wolverine aims to increase the geological confidence and is anticipated to enhance the classification of the Inferred Mineral Resource in future estimates. A key component of this program has been the development of a new deformation intensity spatial model, which for the first time provides a structured framework to improve the understanding of the deposit’s geology.

Executive Chairman Mr. Nicholas Curtis commented:

“The new assay results are very encouraging and emphasise the unique nature of the Browns Range system. These results materially increase confidence in the development of the Wolverine deposit as the first mine within the larger Browns Range system. The exceptional results of the newest Wolverine resource definition drilling program and the increased geological understanding from the drill results and the structural association model supports our regional geological understanding and suggests high-grade opportunities beyond the Wolverine deposit out across the broader Browns Range system. This is encouraging for future exploration success. We are grateful that the Company was able to progress this Program as a result of the grant monies received from the Federal Government. We also are very appreciative of the support we have received from our Native Title Partners - The Jaru People who assisted in ensuring required heritage surveys were completed prior to the campaign commencing. The completion of this drilling program is anticipated in mid-May, and the consequential re-evaluation of our mine plan is due in the fourth quarter of this calendar year, the timing of which aligns well with the Company’s planned FID timing.”


About us:

Northern Minerals Limited (ASX: NTU) (Northern Minerals, or the Company) owns 100% of the Browns Range Project (Project) in northern Western Australia, tenements uniquely rich in the heavy rare earth elements dysprosium (Dy) and terbium (Tb).


Contact details:

Jane Morgan

jm@janemorganmanagement.com.au

Media

More from this category

  • CharitiesAidWelfare, Finance Investment
  • 14/10/2024
  • 13:00
Media alert

On October 29th and 30th, ICMEC Australia will shine a light on the critical battle against child sexual exploitation.

ICMEC Australia will spotlight the critical fight against child sexual exploitation at the SaferAI for Children Summit and the ICMEC Australia Symposium, both taking place in Sydney in late October. The Safer AI for Children Summit on October 29 will explore the role of AI in victim identification and preventive strategies against child sexual exploitation (CSE). The following day, the Financial Crime Symposium on October 30 will bring together leaders from financial services, cryptocurrency, travel, telecoms, ISPs, law enforcement, and the public sector to enhance collaboration in combatting and preventing child sexual exploitation. These initiatives will highlight ongoing efforts to…

  • Finance Investment, Medical Health Aged Care
  • 14/10/2024
  • 09:42
Jane Morgan Management

LTR Pharma (ASX:LTP) SPONTAN® Achieves 470% Faster Absorption in Completed Pivotal Study

Sydney, Australia – 14 October 2024 – LTR Pharma Limited (ASX: LTP) (“LTR Pharma” or “the Company”) is pleased to announce the successful completion of the pivotal clinical study for SPONTAN®, the Company’s novel intranasal formulation of vardenafil for the treatment of erectile dysfunction (ED). The study’s pharmacokinetic and safety data demonstrate SPONTAN’s rapid onset of action and enhanced bioavailability compared to traditional oral ED medications, positioning it as a potential market disruptor in the global ED market. Key Highlights: 470% Faster Absorption: SPONTAN® achieved a time to maximum plasma concentration (Tmax) of just 12 minutes, compared to 56 minutes…

  • Contains:
  • Building Construction, Finance Investment
  • 14/10/2024
  • 09:00
UNSW Sydney

Construction nightmares: How builder bankruptcies are costing Aussie homeowners millions

If there is an industry in Australia that needs confidence right now, it’s the residential construction sector. Yet, at a time of unprecedented need…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.